Glenmark gets USFDA approval for Rythmol SR generic Ruby Khatun Khatun13 Sept 2017 2:08 PM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
Strides Shasun gets USFDA nod for kidney stone tablets Ruby Khatun Khatun13 Sept 2017 1:41 PM ISTNew Delhi: Strides Shasun on Tuesday said it has received approval from the US health regulator for potassium citrate extended release tablets used to...
Lupin gets USFDA nod to market anti-infections tablets Ruby Khatun Khatun12 Sept 2017 10:21 AM ISTNew Delhi: Drug firm Lupin has received approval from the US health regulator to market its generic Doxycycline hyclate tablets, used for the...
Novartis hopeful for novel heart drug, despite modest benefit Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection...
FDA approves Mavyret for Hepatitis C Ruby Khatun Khatun10 Aug 2017 9:45 AM ISTThe U.S. Food and Drug Administration (FDA) approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV)...
Zydus Cadila gets USFDA nod to market HIV drug Ruby Khatun Khatun10 Aug 2017 9:30 AM ISTNew Delhi: Drug firm Zydus Cadila on Tuesday said it has received the tentative approval from the US health regulator to market Abacavir and...
Zydus Cadila gets USFDA nod to market alcohol abstinence drug Ruby Khatun Khatun29 May 2017 11:56 AM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Acamprosate calcium delayed-release tablets used for...
